| Product NDC: | 65597-114 |
| Proprietary Name: | Tribenzor |
| Non Proprietary Name: | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide |
| Active Ingredient(s): | 5; 12.5; 20 mg/1; mg/1; mg/1 & nbsp; olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65597-114 |
| Labeler Name: | Daiichi Sankyo, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA200175 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100731 |
| Package NDC: | 65597-114-10 |
| Package Description: | 10 BLISTER PACK in 1 BOX (65597-114-10) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
| NDC Code | 65597-114-10 |
| Proprietary Name | Tribenzor |
| Package Description | 10 BLISTER PACK in 1 BOX (65597-114-10) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
| Product NDC | 65597-114 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20100731 |
| Marketing Category Name | NDA |
| Labeler Name | Daiichi Sankyo, Inc. |
| Substance Name | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL |
| Strength Number | 5; 12.5; 20 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |